According to a recent LinkedIn post from Acclaro Medical, the company is promoting an in‑person Acclaro Aesthetics Academy event in Napa, California focused on 2910 nm fiber laser technology for skin resurfacing. The post highlights sessions on periorbital rejuvenation, advanced scar remodeling, skin of color best practices, and live treatment demonstrations led by multiple physicians and industry experts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also emphasizes business-oriented content, including return-on-investment strategies, one-on-one marketing consultations, expert panels, and networking activities. For investors, this suggests Acclaro Medical is using educational and training programs as a commercial lever to drive practitioner adoption of its UltraClear Laser and AuraLux platforms, which could support procedure utilization, recurring revenue potential, and brand positioning in the aesthetic laser segment.
By framing the event around “measurable practice growth,” the post appears to target clinic owners and practitioners focused on profitability as well as clinical outcomes. If participation and engagement are strong, such initiatives may help deepen customer relationships, differentiate Acclaro’s fiber laser technology from competitors, and potentially accelerate market penetration in skin resurfacing and aesthetic practices.

